tiprankstipranks
MaxCyte raises FY24 core business revenue view to 6%-8% from flat to up 5%
PremiumThe FlyMaxCyte raises FY24 core business revenue view to 6%-8% from flat to up 5%
13d ago
MaxCyte Streamlines Workforce and Boosts Revenue Outlook
Premium
Company Announcements
MaxCyte Streamlines Workforce and Boosts Revenue Outlook
13d ago
MaxCyte Expands Stock Capital Amid Cell Therapy Growth
Premium
Company Announcements
MaxCyte Expands Stock Capital Amid Cell Therapy Growth
20d ago
MaxCyte Files Quarterly Report, Highlights Financial Progress
PremiumCompany AnnouncementsMaxCyte Files Quarterly Report, Highlights Financial Progress
2M ago
MaxCyte reports Q3 EPS (11c), consensus (12c)
Premium
The Fly
MaxCyte reports Q3 EPS (11c), consensus (12c)
2M ago
MaxCyte Director Sells Shares Amid Active Trading
Premium
Company Announcements
MaxCyte Director Sells Shares Amid Active Trading
2M ago
MaxCyte appoints Cynthia Collins to board of directors
PremiumThe FlyMaxCyte appoints Cynthia Collins to board of directors
2M ago
MaxCyte Strengthens Board with Cynthia Collins Appointment
Premium
Company Announcements
MaxCyte Strengthens Board with Cynthia Collins Appointment
2M ago
MaxCyte to Unveil Q3 2024 Financial Results
Premium
Company Announcements
MaxCyte to Unveil Q3 2024 Financial Results
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100